Login to Your Account



RNAi Companies Ribopharma, Alnylam Merge, Raise $24.6M

By Brady Huggett


Tuesday, July 8, 2003
A hot young section of the industry is seeing some consolidation already, as Alnylam Pharmaceuticals Inc. merged with its counterpart in Germany, Ribopharma AG, and concurrently raised $24.6 million in private financing to build a bigger, stronger entity. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription